Skip to main content
SpringerLink
Log in

Psychiatric Aspects of Parkinson’s Disease

  • Chapter
Psychiatry for Neurologists

Part of the book series: Current Clinical Neurology ((CCNEU))

  • 1422 Accesses

Abstract

Parkinson’s disease (PD) has a special place in neuropsychiatry. Along with progressive supranuclear palsy (PSP), it has been a paradigm for “subcortical” cognitive dysfunction, including dementia, as well as a model for affective disturbances occurring as an intrinsic part of the degenerative process. Although defined clinically by its motor features, PD is clearly a neurobehavioral syndrome, with 90% of patients affected by neuropsychiatric disturbances at some point during the course of the disease (1). Furthermore, psychopathology in PD constitutes a greater stress for caregivers than motor dysfunction, with dementia and psychosis the most devastating and important precipitants of nursing home placement.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aarsland D, Larsen JP, Lim NG et al. Range of neuropsychiatric disturbances in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 1999; 67:492–496.

    Article  PubMed  CAS  Google Scholar 

  2. Menza M, Marsh L. Psychiatric issues in Parkinson’s disease: a practical guide. London: Taylor and Francis. In press.

    Google Scholar 

  3. McDonald WM, Richard I, DeLong MR. Prevalence, etiology, and treatment of depression in Parkinson’s disease. Biol Psychiatry 2003;54:1363–1375.

    Article  Google Scholar 

  4. Leentjens AFG, Marinus J, Van Hilten JJ, Lousberg R, Verhey FRJ. The contribution of somatic symptoms to the diagnosis of depressive disorder in Parkinson’s disease: a discriminant analytic approach. J Neuropsychiatry Clin Neurosci 2003:15:74–77.

    PubMed  CAS  Google Scholar 

  5. Shulman LM, Taback RL, Rabinstein AA, Weiner WJ. Non-recognition of depression and other non-motor symptoms in Parkinson’s disease. Parkinsonism Rel Disord 2002;8:193–197.

    Article  CAS  Google Scholar 

  6. Marsh L. Anxiety disorders in Parkinson’s Disease. Intl Rev Psychiatry 2000;12:307–318.

    Article  Google Scholar 

  7. Richard IH, Justus AW, Kurlan R. Relationship between mood and motor fluctuations in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 2001;13:35–41.

    PubMed  CAS  Google Scholar 

  8. Pluck GC, Brown RG. Apathy in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2002;73:636–642.

    Article  PubMed  CAS  Google Scholar 

  9. Dubois B, Pillon B. Cognitive deficits in Parkinson’s disease. J Neurol 1997; 244:2–8.

    Article  PubMed  CAS  Google Scholar 

  10. Dubois B, Pillon B. Dementia in Parkinson’s disease. In: Wolters EC, Sheltens Ph, Berendse HW, eds. Mental dysfunction in Parkinson’s disease II. Utrecht: Academic Pharmaceutical Productions; 1999:165–176.

    Google Scholar 

  11. Aarsland D, Laake K, Larsen JP, Janvin C. Donepezil for cognitive impairment in Parkinson’s disease: a randomized controlled study. J Neurol Neurosurg Psychiatry 2002;72:708–712.

    Article  PubMed  CAS  Google Scholar 

  12. Leroi I, Brandt J, Reich SG, et al. Randomized placebo-controlled trial of donepezil for cognitive impairment in Parkinson’s disease. Intl J Ger Psychiatry 2004;19:1–8.

    Article  Google Scholar 

  13. Emre M, Aarsland D, Albanese A, et al. Rivastigmine for dementia associated with Parkinson’s disease. N Engl J Med 2004;351(24):2509–2518.

    Article  PubMed  CAS  Google Scholar 

  14. Aarsland D, Larsen JP, Cummings JL, Laake K. Prevalence and clinical correlates of psychotic symptoms in Parkinson Disease. A community-based study. Arch Neurol 1999;56:595–601.

    Article  PubMed  CAS  Google Scholar 

  15. Poewe W. Psychosis in Parkinson’s disease. Mov Disord 2003;18:S80–S87.

    Article  PubMed  Google Scholar 

  16. Factor SA, Feustel PJ, Friedman JH, et al. Long term outcome of Parkinson’s disease patients with psychosis. Neurology 2003;60:1756–1761.

    PubMed  CAS  Google Scholar 

  17. Fernandez HH, Trieschmann ME, Friedman JH. Treatment of psychosis in Parkinson’s disease: Safety considerations. Drug Saf 2003;26:643–659.

    Article  PubMed  CAS  Google Scholar 

  18. Baron MS, Vitek JL, Bakay RA, et al. Treatment of advanced Parkinson’s disease by unilateral posterior GPi pallidotomy: 4-year results of a pilot study. Mov Disord 2000; 5:230–237.

    Article  Google Scholar 

  19. Anderson KE, Mullins J. Behavioral changes associated with deep brain stimulation surgery for Parkinson’s disease. Curr Neurol Neurosci Rep 2003;3:306–313.

    Article  PubMed  Google Scholar 

  20. Berney A, Vingerhoets F, Perrin A, et al. Effect on mood of subthalamic deep brain stimulation for Parkinson’s disease: a consecutive series of 24 patients. Neurology 2002;59:1427–1429.

    PubMed  CAS  Google Scholar 

  21. Funkiewiez A, Ardouin C, Caputo E, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood and behavior in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2004;75:834–839.

    Article  PubMed  CAS  Google Scholar 

  22. Kulisevsky J, Berthier ML, Gironell A, Pascual-Sedano B, Molet J Parés P. Mania following deep brain stimulation for Parkinson’s disease. Neurology 2002;59:1421–1424.

    PubMed  CAS  Google Scholar 

  23. Dujardin K, Blairy S, Debfevre L, et al. Subthalamic nucleus stimulation induces deficits in decoding emotional facial expressions in Parkinson’s disease. J Neurol Neurosurg and Psychiatry 2004;75:202–208.

    CAS  Google Scholar 

  24. Saint-Cyr JA, Trepanier LL, Kumar R, Lozano AM, Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson’s disease. Brain 2000;123:2091–2108.

    Article  PubMed  Google Scholar 

  25. Friedman JH, Chou KL. Sleep and fatigue in Parkinson’s disease. Parkinsonism Relat Disord 2004;10(Suppl 1):S27–S35.

    Article  PubMed  Google Scholar 

  26. Garber CE, Friedman JH. Effects of fatigue on physical activity in patients with Parkinson’s disease. Neurology 2003:60:1119–1124.

    Article  PubMed  Google Scholar 

  27. Herlofson K, Larsen JP. The influence of fatigue on health-related quality of life in patients with Parkinson’s disease. Acta Neurol Scand 2003;107:1–6.

    Article  PubMed  CAS  Google Scholar 

  28. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosis. Arch Neurol. 1989;46:1121–1123.

    PubMed  CAS  Google Scholar 

  29. Kurlan R. Disabling repetitive behaviors in Parkinson’s disease. Mov Disord 2004;19:433–437.

    Article  PubMed  Google Scholar 

  30. Uitti R, Tanner CM, Rajput AH, Goetz CG, Klawans HL, Thiessen B. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol 1989;12:375–383.

    Article  PubMed  CAS  Google Scholar 

  31. Voon V. Repetition, repetition, and repetition: compulsive and punding behaviors in Parkinson’s disease. Mov Disord 2004;19:367–370.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Psychiatry and Neurology, Johns Hopkins Medical Center, The Johns Hopkins University School of Medicine, Baltimore, MD

    Laura Marsh MD

  2. Parkinson’s Disease and Movement Disorders Center, NeuroHealth, Warwick, RI

    Joseph H. Friedman MD

  3. Department of Clinical Neurosciences, Brown University Medical School, Providence, RI

    Joseph H. Friedman MD

Authors
  1. Laura Marsh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph H. Friedman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Psychiatry and Neurosciences, University of California, San Diego

    Dilip V. Jests MD

  2. Department of Psychiatry and Neurosciences, VA San Diego Healthcare System, San Diego, CA

    Dilip V. Jests MD

  3. Parkinson’s Disease and Movement Disorders Center, NeuroHealth, Warwick, RI

    Joseph H. Friedman MD

  4. University Medical School, Providence, RI

    Joseph H. Friedman MD

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Marsh, L., Friedman, J.H. (2006). Psychiatric Aspects of Parkinson’s Disease. In: Jests, D.V., Friedman, J.H. (eds) Psychiatry for Neurologists. Current Clinical Neurology. Humana Press. https://doi.org/10.1007/978-1-59259-960-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-960-8_14

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-483-8

  • Online ISBN: 978-1-59259-960-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation